webleads-tracker

Not Every Conflict of Interest Produces the Same Vote on FDA Panels

For the past decade,Pharma Compliance Info Not Every Conflict of Interest Produces the Same Vote on FDA Panels US Sunshine Act
the FDA has grappled with competing views about the potential for conflicts of interest among its advisory panel members to unduly influence decisions about which drugs to recommend for regulatory approval.
At one point, the agency worried aloud that its own regulations made it difficult to find qualified experts, although that has been less of a problem lately.
But as FDA officials continue to monitor the issue, a new study offers some insight into how the agency may want to vet the experts who are asked to serve on advisory committees. As it turns out, panel members who have financial ties only to the drug maker seeking approval for a medicine are 1.5 times more likely to vote to favorably for the company than members with no financial ties.
To read this article by Ed Silverman, The Wall Street Journal

Check Also

Pharma Compliance Info The Patient Advocacy Groups that Accept the Most Big Pharma Money US Sunshine Act

The Patient Advocacy Groups that Accept the Most Big Pharma Money

Eight out of ten patient advocacy groups accept money from drug and medical device companies. …

X